Ironwood Pharmaceuticals





Ebit Cambio Fecha
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Ardelyx USD 7.12M 19.62M 2025-09
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Coherus Biosciences USD -45.43M 3.19M 2025-03
Esperion Therapeutics USD -16.03M 11.51M 2024-09
Exact Sciences USD -25M 22.85M 2025-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Lexicon Pharmaceuticals USD -49.63M 5.39M 2023-09
MacroGenics USD 20.16M 55.51M 2025-09
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -5.5M 11.1M 2025-03
Pacira USD 3.19M 9.96M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12


Ironwood Pharmaceuticals - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.